This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Mycophenolate mofetil

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Mycophelolate is metabolised to mycopheolic acid which inhibits the synthesis of the purine nucleotide guanine. Mycophenolate mofetil inhibits the proliferation of B and T cells in response to antigen stimulation.

The addition of mycophenolate mofetil to the standard immunosuppressant regimen of cyclosporin and prednisolone in kidney transplant recipients reduces the frequency of acute rejection episodes.

Mycophenolate mofetil may have a role in the treatment of acute rejection.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.